Pharma
10 stories · United States edition
US Pharma Companies Boost Domestic Manufacturing Amid Global Shifts
Amid global supply chain disruptions, US pharmaceutical firms are ramping up domestic manufacturing investments.
FDA Issues New Safety Warning for Widely Used Prescription Drug
The FDA has issued a safety alert for a popular prescription medication, urging healthcare providers to reassess patient treatment plans.
US Pharmacies Struggle as Drug Shortages Intensify
Rising drug shortages are creating operational hurdles for US pharmacies, impacting patient care and medication access.
FDA Greenlights Innovative Therapy for Rare Genetic Disorder
The FDA's approval of a new drug offers hope for patients with a rare genetic disorder, marking a significant advancement in personalized medicine.
US Health Insurers Face Surge in Weight-Loss Drug Spending
US insurers grapple with skyrocketing costs as demand for new weight-loss drugs rises.
GLP-1 Drug Demand Outstrips Supply Across the United States
The surge in demand for GLP-1 drugs in the US is creating significant supply challenges for healthcare providers.
Prescription Drug Prices: A Persistent Issue in the USA
Rising prescription drug costs continue to strain US consumers, heightening calls for regulatory reforms.
Ongoing Supply Chain Issues Disrupt GLP-1 Drug Availability in the U.S.
Supply chain disruptions continue to impede access to GLP-1 drugs, affecting diabetes care across the U.S.
Ozempic and Mounjaro: New Concerns Over Hair Loss in the USA
Reports suggest Ozempic and Mounjaro may cause hair loss, stirring debate among US patients and healthcare professionals.
FDA Panel Endorses Replimune's New Melanoma Therapy
A key FDA panel has endorsed Replimune's new melanoma treatment, marking a significant step toward wider use in the US.